Study of Two rTMS Treatments for Depression in U.S. Military Members and Veterans With Concussion History
Led by Henry M. Jackson Foundation for the Advancement of Military Medicine · Updated on 2026-04-29
198
Participants Needed
3
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the safety, effectiveness, and tolerability of two repetitive transcranial magnetic stimulation rTMS protocols targeting the dorsolateral prefrontal cortex to reduce depression symptoms in U.S. military members and veterans with a history of concussion or mild traumatic brain injury. The study uses a randomized, double-blind, Bayesian adaptive design to compare individualized connectome targeted accelerated intermittent Theta Burst Stimulation and scalp-targeted stimulation in this specific population.
Participants are assigned randomly to one of three groups active rTMS with individualized connectome targeting, active rTMS with resting state functional MRI-based targeting, or a sham placebo rTMS group. These treatments are delivered as device-based brain stimulation therapies designed to assess their impact on depressive symptoms. The study includes an initial treatment phase followed by post-intervention assessments and a 6-month follow-up period.
During the study, participants will undergo evaluations using the Montgomery-Asberg Depression Rating Scale to measure changes in depression symptoms from baseline through post-intervention and at 6 months. Additional assessments include self-reported depression scales, quality of life related to brain injury, PTSD symptoms, and brain connectivity via MRI scans. Researchers will monitor treatment compliance, adverse events, and overall safety throughout the trial, which lasts up to 6 months after final treatment.
CONDITIONS
Brief Title
rTMS for Military TBI-related Depression
Research Team
E
Elizabeth N Diaz Nelson, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Henry M. Jackson Foundation for the Advancement of Military Medicine
Lead Sponsor
Uniformed Services University of the Health Sciences
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Individualized aiTBS rTMS (trial investigational)
Sham rTMS (trial comparator)
Standard clinical rTMS (contextual comparator)
What it is
An investigational accelerated intermittent theta burst stimulation (aiTBS) rTMS protocol guided by individualized connectome targeting
A sham (placebo) rTMS control procedure matching trial setup without active stimulation
Standard repetitive transcranial magnetic stimulation used in treatment‑resistant major depression
Role in trial
One of two active treatment arms assessing efficacy and tolerability
Placebo comparator to measure trial treatment effects
Representative of current clinical rTMS practice for resistant depression, not part of the study arms
Primary use
To reduce depressive symptoms in service members/veterans with remote mild TBI
Control to isolate effects of active stimulation
To treat persistent major depressive disorder after failure of medications
Sham rTMS sessions mimicking treatment without active magnetic stimulation
Typical rTMS protocols involve daily sessions (eg, high‑frequency over left DLPFC) over several weeks
Evidence status
Efficacy is under investigation; trial will assess whether it improves depression after TBI
Serves to assess placebo response; no direct clinical efficacy
Proven to reduce depressive symptoms in treatment‑resistant depression generally
Important risks
Risks under evaluation; rTMS may carry seizure risk in individuals with elevated risk
No active stimulation; minimal risk beyond procedural discomfort
Generally well tolerated; rare seizure risk; safety supported in treatment‑resistant depression
Important limitations
Efficacy and safety in TBI‑related depression unknown until study completes
Not a therapeutic option beyond serving as placebo control
Evidence for rTMS in TBI‑related depression is limited and mostly shows short‑term benefits
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 55Years
All Genders
Eligibility Criteria
You may qualify if you...
Age 18 to 55 years at the time of consent
Current or former US military service member eligible for care at a Military Treatment Facility or Veterans Administration Medical Center
Able to provide written, informed consent in English
History of concussion (mild traumatic brain injury) more than 6 months but less than 26 years prior to consent, confirmed by TBI Screener or medical records
Baseline Montgomery-Asberg Depression Rating Scale (MADRS) score greater than 13 indicating mild to moderate depressive symptoms
Stable psychotropic medication regimen for 6 weeks and stable behavioral therapy regimen for 12 weeks prior to enrollment
Female participants with child-bearing potential must use effective birth control during the study
Under care of a primary care or behavioral health provider
You will not qualify if you...
History of unprovoked seizures or recent seizures related to concussion
Family history of two or more unprovoked seizures in a first degree relative
History of moderate, severe, or penetrating traumatic brain injury
Intracranial lesions that increase seizure risk or interfere with MRI data
Contraindications to awake 3T MRI without contrast
Severe claustrophobia preventing MRI
Severe or uncontrolled heart disease
Presence of cardiac pacemaker or intracardiac lines
Implants or prostheses unsafe with MRI or TMS or that interfere with data
Rapidly progressive illnesses such as late-stage cancer or major organ failure
History of bipolar disorder or schizophrenia spectrum disorders
Substance-induced mood disorder, active psychosis, or depression from other medical illness
Severe or uncontrolled substance use
Prior open-label TMS or recent neurostimulatory treatments
Suicide attempt within 6 months prior to enrollment
Right upper extremity amputation preventing motor threshold calibration
Inability to complete the study timeline
Prisoner or legally restricted freedom of movement
Other investigator concerns affecting safety, participation, or data validity
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - Up to the duration of the active rTMS treatment sessions
Participants receive repetitive transcranial magnetic stimulation (rTMS) or sham rTMS as part of the trial intervention.
Multiple visits during treatment sessions
Follow-up
Duration - Up to 6 months after the final rTMS session
Participants are monitored for treatment response and safety after the final rTMS session, including assessments up to 6 months.
Visits within 10 working days post-intervention and assessments up to 6 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Testing a New Culturally Centered Treatment Model for Latinx Youth With Suicidal Thoughts and Behaviors
Remote Tai ChiQigong vs Health Education for Depression in Older Adults Living with HIV A Randomized Clinical Trial
Effectiveness and Timing of a Smartphone-Based Social Support Intervention for Adults with Elevated Depressive Symptoms Seeking Psychotherapy
Study of Stress and Emotion Skills in Children Aged 8 to 12 With Depressive Symptoms to Help Develop a Gamified Emotion Regulation App
Auditory Training to Improve Hearing After Mild Traumatic Brain Injury for Adults Aged 18 to 55
Testing EMDR Therapy Combined with Brain Stimulation tDCS for Treating Fibromyalgia in Women Aged 18 to 70
Branched Chain Amino Acids BCAAs to Promote Recovery in Adolescents and Young Adults After Concussion A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Study of Behavioral Activation Treatment to Prevent and Treat Depression in Adults Aged 65 and Older in a Swedish Municipal Setting
Comparing Cognitive Behavioral Therapy and Brief Behavioral Therapy for Insomnia in Military Members with Mild Traumatic Brain Injury and Postconcussive Symptoms
Technology-Based Cancer Pain Management Program with Personalized Support for Asian American Breast Cancer Survivors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Adaptive trial for the treatment of depressive symptoms associated with concussion using accelerated intermittent theta burst stimulation (ADEPT): rationale, design and methods.
Lindsay M Oberman, Adriana I Penafiel, Rachel Dieterich...